Philippines - English - FDA (Food And Drug Administration)

getz pharma (phils.), inc. - insulin human (rdna) - suspension for injection (im/sc) - 100 iu/ml - anti-diabetic - for the treatment of diabetes mellitus type i; diabetes mellitus type ii either alone or in combination with oral anti-diabetic agents; emergency management of diabetic ketoacidosis; adult patients with diabetes mellitus for the control of hyperglycemia should be used in regimens that include a longer-acting insulin.

Philippines - English - FDA (Food And Drug Administration)

getz pharma (phils.), inc. - insulin human (rdna) - suspension for injection (im/sc) - 100 iu/ml - anti-diabetic - for the treatment of diabetes mellitus type i; diabetes mellitus type ii either alone or in combination with oral anti-diabetic agents; emergency management of diabetic ketoacidosis; adult patients with diabetes mellitus for the control of hyperglycemia should be used in regimens that include a longer-acting insulin.

Philippines - English - FDA (Food And Drug Administration)

getz pharma (phils.), inc. - insulin human (rdna) - suspension for injection (im/iv/sc) - 100 iu/ml - anti-diabetic - for the treatment of diabetes mellitus type i; diabetes mellitus type ii either alone or in combination with oral anti-diabetic agents; emergency management of diabetic ketoacidosis; adult patients with diabetes mellitus for the control of hyperglycemia should be used in regimens that include a longer-acting insulin.

Philippines - English - FDA (Food And Drug Administration)

getz pharma phils., inc. - isophane insulin human (rdna) - suspension for injection (im/sc) - 100 iu / ml - anti-diabetic - for the treatment of diabetes mellitus type i; diabetes mellitus type ii either alone or in combination with oral anti-diabetic agents; emergency management of diabetic ketoacidosis; adult patients with diabetes mellitus for the control of hyperglycemia should be used in regimens that include a longer-acting insulin.

Philippines - English - FDA (Food And Drug Administration)

getz pharma phils., inc. - regular, regular insulin (rdna, human) - regular insulin (im, iv, sc) - 100 iu / ml - anti-diabetic - for the treatment of diabetes mellitus type i; diabetes mellitus type ii either alone or in combination with oral anti-diabetic agents; emergency management of diabetic ketoacidosis; adult patients with diabetes mellitus for the control of hyperglycemia should be used in regimens that include a longer-acting insulin.

Philippines - English - FDA (Food And Drug Administration)

getz pharma phils., inc. - biphasic isophane human insulin (rdna) , isophane suspension , soluble insulin - suspension for injection (im / sc) - 100iu/ml - anti-diabetic - for the treatment of diabetes mellitus type i; diabetes mellitus type ii either alone or in combination with oral anti-diabetic agents; emergency management of diabetic ketoacidosis; adult patients with diabetes mellitus for the control of hyperglycemia should be used in regimens that include a longer-acting insulin.

Philippines - English - FDA (Food And Drug Administration)

getz pharma phils., inc. - alendronic acid - tablet - 70mg - anti-osteoporotic - – in postmenopausal women for the treatment of osteoporosis to prevent fractures, including those of the hip and spine (vertebral compression fractures). – in postmenopausal women who are at risk of developing osteoporosis. – for the treatment of osteoporosis in men to prevent fractures. – for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women. – for the treatment of paget’s disease of bone in men and women.

Philippines - English - FDA (Food And Drug Administration)

getz pharma (phils.) inc.; distributor: getz pharma (phils.) inc. - celecoxib - capsule - 100mg

Philippines - English - FDA (Food And Drug Administration)

getz pharma (phils.), inc.; distributor: getz pharma (phils.), inc. - celecoxib - capsule - 200mg

Philippines - English - FDA (Food And Drug Administration)

getz pharma (phils.), inc. - clarithromycin - extended release tablet - 500mg - antibiotic - for treatment of pharyngitis/tonsillitis; acute maxillary sinusitis; acute bacterial exacerbation of chronic bronchitis; community-acquired pneumonia; uncomplicated skin and skin structure infections; helicobacter pylori and duodenal ulcer disease when used in combination with amoxicillin and lansoprazole or omeprazole; h. pylori and active duodenal ulcer when used in combination with omeprazole or ranitidine bismuth citrate; prevention of disseminated mac disease in patients with advanced hiv infection; treatment of disseminated mycobacterial infections caused by m. avium or mycobacterium intracellulare .